Isotype choice for chimeric antibodies affects binding properties.
Maurice M. Morelock(Boehringer Ingelheim (Brazil)), David S. Scher(Boehringer Ingelheim (Brazil)), Robert Rothlein(Thomas Jefferson University), Michael K. Robinson(Boehringer Ingelheim (Brazil)), Edward T. Graham(Boehringer Ingelheim (Brazil)), Stephen H. Norris(Boehringer Ingelheim (Brazil)), John P. Sabo(Boehringer Ingelheim (Brazil)), Raymond J. Owens(University of Oxford), David J. King(AnaBios (United States)), Susan Bright(Boehringer Ingelheim (Brazil))
Cited by 51
Related Papers
A versatile ligation-independent cloning method suitable for high-throughput expression screening applications
|Nucleic Acids Research|2007|571
High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable Marker
|Nature Biotechnology|1992|465
In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.
|The Journal of Immunology|1990|371
A PHASE I TRIAL OF IMMUNOSUPPRESSION WITH ANTIIC AM-1 (CD54) mAb IN RENAL ALLOGRAFT RECIPIENTS
|Transplantation|1993|300